INS and type 2 diabetes mellitus: Biochemical evidence indicates that insulin promotes Hcy metabolism by activating cystathionine β-synthase (CBS), whereas the insulin resistance characteristic of T2DM disrupts this pathway, leading to reduced Hcy clearance (15, 16).